EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epithelial–Mesenchymal Transition Markers in Clear Cell Renal Cell Carcinoma: Expression Patterns and Prognostic Significance

Lara Smoljo, Tonka Mateljak, Anita Racetin, Petar Todorović iD, Jelena Komić iD, Luka Komić iD, Petar Đolonga, Danijel Antonio Grubišić, Sandra Kostić iD, Katarina Vukojević iD, Nela Kelam iD

Journal of Personalized Medicine · 24.05.2026 · 16 (6) · 279

DOI: 10.3390/jpm16060279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 24.05.2026. Verfasst von Lara Smoljo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Histology and Embryology, Laboratory for Early Human Development, University of Split School of Medicine, Šoltanska 2A, 21000 …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, The Ministry of Science, Education and Youth of the Republic of Croatia under the National Recovery and Resilience Plan 2021-2026 (NRRP), funded by the Europea….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of renal cancer, characterized by frequent metastasis and poor prognosis. Epithelial–mesenchymal transition (EMT) plays a pivotal role in tumor progression. Protocadherin 9 (PCDH9) has emerged as a potential tumor suppressor, but its relationship with EMT markers in ccRCC remains unclear. This study aimed to investigate the expression patterns and prognostic significance of PCDH9, β-catenin (CTNNB1), Snail (SNAI1), and Vimentin (VIM) in ccRCC.

Methods

Immunofluorescence analysis was performed on formalin-fixed paraffin-embedded tissue sections from 48 ccRCC patients (31 low-grade, 17 high-grade) and adjacent normal renal cortex. Findings were validated using The Cancer Genome Atlas (TCGA-KIRC) dataset via GEPIA2/GEPIA3 platforms, including differential expression, correlation, and survival analyses. Results:PCDH9 mRNA was significantly downregulated in ccRCC tumors (TCGA-KIRC), while VIM was upregulated at the transcriptomic level. Tissue-level immunofluorescence quantification revealed discordant patterns, highlighting the influence of cellular heterogeneity on bulk protein assessment. The strong positive correlation between PCDH9 and CDH1 observed in normal kidney was completely lost in tumor tissue. Unexpectedly, PCDH9 showed positive correlations with EMT transcription factors (ZEB1, SNAI1) in tumors. In univariate survival analysis, high PCDH9 and CTNNB1 expression were associated with improved overall survival. Multivariate Cox regression revealed endpoint-specific prognostic signatures: VIM independently predicted disease progression, while SNAI1 predicted overall mortality. CTNNB1 was consistently protective across both endpoints.

Conclusions

Our findings support a tumor-suppressive role for PCDH9 in ccRCC and reveal disruption of epithelial adhesion molecule co-regulation during tumorigenesis. The identification of endpoint-specific prognostic signatures has implications for patient stratification and suggests that ccRCC exhibits a partial EMT phenotype rather than classical EMT.

Schlagwörter

Stichwörter der Autor:innen

CTNNB1EMTPCDH9SNAI1VIMclear cell renal cell carcinomaepithelial–mesenchymal transitionvimentinβ-catenin

Autor:innen und Institutionen

  • Department of Anatomy, Histology and Embryology, Laboratory for Early Human Development, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.
  • Center for Translational Research in Biomedicine, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.
  • Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia.
  • Department of Pathology, Forensic Medicine and Cytology, University Hospital of Split, 21000 Split, Croatia.
  • Mediterranean Institute for Life Sciences (MedILS), University of Split, Meštrovićevo Šetalište 45, 21000 Split, Croatia.

ORCID-Profile: Petar Todorović, Jelena Komić, Luka Komić, Sandra Kostić, Katarina Vukojević, Nela Kelam

Förderung

  • Croatian Science Foundation
  • The Ministry of Science, Education and Youth of the Republic of Croatia under the National Recovery and Resilience Plan 2021-2026 (NRRP), funded by the Europea…

Zitieren

APA

Smoljo, L., Mateljak, T., Racetin, A., Todorović, P., Komić, J., Komić, L., Đolonga, P., Grubišić, D. A., Kostić, S., Vukojević, K., & Kelam, N. (2026). Epithelial–Mesenchymal Transition Markers in Clear Cell Renal Cell Carcinoma: Expression Patterns and Prognostic Significance. Journal of Personalized Medicine, 16(6), 279. https://doi.org/10.3390/jpm16060279

Vancouver

Smoljo L, Mateljak T, Racetin A, Todorović P, Komić J, Komić L, et al. Epithelial–Mesenchymal Transition Markers in Clear Cell Renal Cell Carcinoma: Expression Patterns and Prognostic Significance. Journal of Personalized Medicine. 2026;16(6):279. doi:10.3390/jpm16060279

BibTeX
@article{Smoljo2026,
  author = {Smoljo, Lara and Mateljak, Tonka and Racetin, Anita and Todorović, Petar and Komić, Jelena and Komić, Luka and Đolonga, Petar and Grubišić, Danijel Antonio and Kostić, Sandra and Vukojević, Katarina and Kelam, Nela},
  title = {Epithelial–Mesenchymal Transition Markers in Clear Cell Renal Cell Carcinoma: Expression Patterns and Prognostic Significance},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {279},
  doi = {10.3390/jpm16060279}
}
Kostenlos starten →